4 ms·
Holmes jury learns how Theranos duped a savvy health care investor
- KKKKkkkk1 5y agoGrossman continued to press for more information. He spoke with Channing Robertson, who was a Theranos board member and a professor of chemical engineering at Stanford. Over two conversations, Robertson told Grossman that the company’s technology was sound. This is the most galling part. Dr. Robertson is currently a professor emeritus at Stanford. When Jan Hendrik Schoen [0] was caught doing scientific fraud, his alma mater, University of Konstanz, stripped him of his PhD. I'm not saying Prof. Robertson should be stripped of his PhD, but I feel like Stanford could make at least some symbolic gesture to distance themselves from this affair. [0] https://en.wikipedia.org/wiki/Sch%C3%B6n_scandal https://en.wikipedia.org/wiki/Sch%C3%B6n_scandal
- redis_mlc 5y agoThe Theranos case is much worse than some sophisticated SV investors getting duped. The Theranos board had numerous senior US military ex-officials who were expected to sell into their former commands and the VA system. This woman should spend the rest of her life in jail. What I don't understand is how a non-doctor got significant funding for a medical company, given the amount of regulation that industry faces in the US. It's truly bizarre. I've followed the rise of various medical device and pharma startups, and they all had a senior doctor at the top. (FYI: US doctors can make more money from affiliated hospital lab service companies than traditional patient practise.) Dr. Sherman's Apotex generic pharma company had an incredible rise to the top of Canadian medical companies, worth billions: https://en.wikipedia.org/wiki/Barry_Sherman https://en.wikipedia.org/wiki/Barry_Sherman
- hn_throwaway_99 5y agoEpisodes like this really highlight how Theranos was not just a case of "Silicon Valley overhyping" taken to an extreme, as has often been portrayed in the media. Flat out lying to investors is a cardinal sin in the Valley, and the line between selling a future vision and what your current capabilities are is not really gray. It would have been one thing to say, for example, that "we plan to be able to run 1000 different tests in a year", and not deliver, vs flat out saying "our technology can run all those tests today", which it most definitely couldn't.
- theshadowknows 5y agoWhen I first heard about the Theranos meltdown I was so sure that Holmes was a victim of big pharma trashing her name and her company. But man..as the story unfolds in front of us that is obviously not the case. I’m pretty bummed about it because I was really excited a few years ago when the company was so hot. Hopefully some of their tech or ideas are solid and someone really can build on them to make good healthcare products for people.
- nradov 5y agoNone of their tech or ideas were ever solid. It is biologically impossible to measure accurate blood levels of all but a few analytes from a fingertip blood drop.
- theshadowknows 5y agoYeah that’s what I’m understanding now. Really would have been amazing if it were possible. If you’ll indulge me, is there some theoretical technology that could enable such a breakthrough or is it so far from possible that it’s not even feasible for some reason?
- hn_throwaway_99 5y agoNo, it's physically impossible. There is plenty of evidence that capillary blood simply isn't homogeneous enough in small volumes to do quantitative analysis. But honestly, I actually don't think that's much of a big deal. The difference between taking a venous draw and doing a finger stick as not as big of a deal as Theranos made it out to be. If instead Theranos had a small, portable analysis machine that could work with small volumes of venous blood, and they had a big deal with Walgreens to use that together with things like low, up-front pricing for tests, I think that still would have been a great advance. Note there are startups like Everlywell basically trying to make that vision (cheap, accessible, up-front pricing for medical tests) possible.
- nradov 5y ago